Komori
Astena Holdings (8095) · InitiativeAchieved

Issuance of Stock Acquisition Rights with Provisions for Adjustment of the Exercise Price through a Third-Party Allotment

First written in FY2020. 2 of 3 entries say "Advanced", first in FY2020. Latest entry: FY2021-Q2.

3entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2020 – FY2021-Q22021: 32021
Same theme, other companies

24 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 69 companies compared. The sentences above are computed from all 69.
Full recordFilings, disclosures and news, newest first
  1. FY2021-Q2AchievedAnnual report

    「All of the share acquisition rights had been exercised by 7 July 2021.」

    All of the share acquisition rights with provisions for adjustment of the exercise price issued through a third-party allotment had been exercised by 7 July 2021. An additional 1,971,000 shares were delivered and ¥1,177.531 million was raised.
  2. FY2021-Q1AdvancedAnnual report

    「During the first quarter accounting period, share acquisition rights relating to bonds with share acquisition rights and other instruments with provisions for adjustment of the exercise price were exercised as follows. … Number of such instruments exercised during the quarter (units): 11,067; number of shares delivered upon exercise during the quarter: 1,106,700; funds raised through exercises during the quarter (¥ thousand): 653,792.」

    Of the share acquisition rights issued through a third-party allotment, 11,067 units were exercised in the first quarter, 1,106,700 shares were delivered and ¥653.792 million was raised.
  3. FY2020AdvancedAnnual report

    「At a meeting of the Company’s Board of Directors held on 30 November 2020, the Company resolved to issue the first series of share acquisition rights through a third-party allotment, with provisions for adjustment of the exercise price. Payment in full of the issue price of these share acquisition rights was completed on 16 December 2020.」

    The Company formulated a detailed plan to issue 67,200 share acquisition rights representing 6.72 million potential shares and raise estimated net proceeds of ¥4,236.209 billion for capital expenditures. Partial exercises had also progressed by the filing date, and 1,106,700 shares had been delivered.
Moved together

"Overseas Expansion and Product Development in Chemicals, New Equipment and Optimal-Site Production" moved the same way as this thread, in the same document, in 3 of its 3 moves.

333333★123456
  1. ★This thread
  2. 1Overseas Expansion and Product Development in Chemicals, New Equipment and Optimal-Site Production3×
  3. 2Sharp Decline in Chemicals Business Revenue and Widening Operating Loss3×
  4. 3Expanding Sales of Generic Pharmaceutical Ingredients and New Materials Through Customer Proposals3×
  5. 4Strengthening the CMC contract research business through the acquisition of all shares in スペラファーマ3×
  6. 5Strengthening Direct Marketing Through the Acquisition of All Shares in マルマンH&B3×
  7. 6Stable Supply of Pharmaceuticals, Capital Investment and Production Efficiency Improvements3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Astena Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.